232 related articles for article (PubMed ID: 30560912)
1. Eyelids metastases from uveal melanoma: clinical and histopathologic features of two cases and literature review.
Martel A; Oberic A; Moulin A; Zografos L; Hamedani M
Eye (Lond); 2019 May; 33(5):767-771. PubMed ID: 30560912
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
3. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
Glasgow BJ; McCannel TA
Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
[TBL] [Abstract][Full Text] [Related]
5. Early satellite metastatic uveal melanoma to the lower eyelid--the first report.
Elabjer BK; Miletić D; Bušić M; Sarić B; Petrović Z; Bradetić T; Bosnar D
Orbit; 2012 Feb; 31(1):27-9. PubMed ID: 22007917
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
7. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing.
Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE
Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347
[TBL] [Abstract][Full Text] [Related]
8. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
9. Contralateral eyelid metastasis of uveal melanoma with further systemic dissemination.
Radovanović AB; Latkovic Z
Vojnosanit Pregl; 2010 Apr; 67(4):336-8. PubMed ID: 20465164
[TBL] [Abstract][Full Text] [Related]
10. Targeted silencing of MART-1 gene expression by RNA interference enhances the migration ability of uveal melanoma cells.
Zhang Y; Jia R; Wang J; Xu X; Yao Y; Ge S; Fan X
Int J Mol Sci; 2013 Jul; 14(7):15092-104. PubMed ID: 23877836
[TBL] [Abstract][Full Text] [Related]
11. Aggressive skull base metastasis from uveal melanoma: a clinicopathologic study.
Yonekawa Y; Kim IK; Gragoudas ES; Njauw CN; Tsao H; Jakobiec FA; Stacy RC
Eur J Ophthalmol; 2014; 24(5):811-3. PubMed ID: 24729140
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous vitiligo following management of uveal melanoma in 6 patients.
Rishi P; Shields CL; Patrick K; Shields JA
JAMA Ophthalmol; 2013 Sep; 131(9):1174-8. PubMed ID: 23887251
[TBL] [Abstract][Full Text] [Related]
13. Two Distinct Uveal Melanomas in the Same Eye.
Nissen EJ; Kalirai H; Damato B; Heimann H; Coupland SE
JAMA Ophthalmol; 2015 Sep; 133(9):1094-6. PubMed ID: 26110363
[No Abstract] [Full Text] [Related]
14. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
[TBL] [Abstract][Full Text] [Related]
15. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
de Vries TJ; Trancikova D; Ruiter DJ; van Muijen GN
Br J Cancer; 1998 Nov; 78(9):1156-61. PubMed ID: 9820172
[TBL] [Abstract][Full Text] [Related]
16. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
18. Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma.
Kiewe P; Bechrakis NE; Schmittel A; Ruf P; Lindhofer H; Thiel E; Nagorsen D
Ann Oncol; 2006 Dec; 17(12):1830-4. PubMed ID: 16971663
[TBL] [Abstract][Full Text] [Related]
19. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy between fluorescence in situ hybridization and multiplex ligation-dependent probe amplification in orbital recurrence of uveal melanoma 26 years after enucleation.
Russo A; Rene C; Coupland SE; Sagili S; Damato B
Ophthalmic Plast Reconstr Surg; 2012; 28(6):e140-2. PubMed ID: 22460679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
